Pharmacogenetic Problems of Antitumor Therapy (A Review)

Author： Sukhanov V. A.   Saprin A. N.   Piruzyan L. A.  

Publisher： Springer Publishing Company

ISSN： 0091-150X

Source： Pharmaceutical Chemistry Journal, Vol.38, Iss.7, 2004-07, pp. : 347-354

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Various Pharmacogenetic Aspects of Antiepileptic Drug Therapy: A Review

By Mann Michael W.  

CNS Drugs, Vol. 21, Iss. 2, 2007-01 ,pp. : 143-164

Adis International

Access to resources Recommend Favorite

Pharmacogenetic differences and drug–drug interactions in immunosuppressive therapy

By Warrington Jill S   Shaw Leslie M  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 3, 2005-10 ,pp. : 487-503

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetic considerations for non-Hodgkin's lymphoma therapy

By Espirito Santo Ana   Medeiros Rui  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 12, 2013-12 ,pp. : 1625-1634

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetic considerations for late life depression therapy

By Pitychoutis Pothitos M   Kokras Nikolaos   Sanoudou Despina   Dalla Christina   Papadopoulou-Daifoti Zeta  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 8, 2013-08 ,pp. : 989-999

Informa Healthcare

Access to resources Recommend Favorite

Antitumor Activity of Silatranes (A Review)

By  

Pharmaceutical Chemistry Journal, Vol. 38, Iss. 1, 2004-01 ,pp. : 3-9

Springer Publishing Company

Access to resources Recommend Favorite